Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factor.

Autor: Brösecke F; Department of Nephrology and Medical Intensive Care, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany., Pfau A; Department of Nephrology and Medical Intensive Care, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany.; MVZ Dialysezentrum (Dialysis Center), Schweinfurt, Germany., Ermer T; Department of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, CT, USA., Dein Terra Mota Ribeiro AB; Department of Nephrology and Medical Intensive Care, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany., Rubenbauer L; Department of Nephrology and Medical Intensive Care, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany., Rao VS; Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA., Burlein S; Department of Nephrology and Medical Intensive Care, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany., Genser B; Department of General Medicine, Centre for Preventive Medicine and Digital Health Baden Württemberg, Ruprecht Karls University, Heidelberg, Germany.; High5Data GmbH, Heidelberg, Germany., Reichel M; Department of Nephrology and Medical Intensive Care, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany., Aronson PS; Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, CT, USA., Coca S; Mount Sinai School of Medicine, Mt. Sinai Hospital, New York, NY, USA., Knauf F; Department of Nephrology and Medical Intensive Care, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany. Felix.Knauf@charite.de.; Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, CT, USA. Felix.Knauf@charite.de.

Publikováno v: Scientific reports [Sci Rep] 2024 May 17; Vol. 14 (1), pp. 11323. Date of Electronic Publication: 2024 May 17.

SLC26A1 is a major determinant of sulfate homeostasis in humans.

Autor: Pfau A; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany., López-Cayuqueo KI; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Max-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany., Scherer N; Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center and.; Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany., Wuttke M; Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center and., Wernstedt A; SYNLAB MVZ Humane Genetik, Munich, Germany., González Fassrainer D; SYNLAB MVZ Humane Genetik, Munich, Germany., Smith DE; Metabolic Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience and., van de Kamp JM; Department of Human Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Ziegeler K; Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Eckardt KU; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Luft FC; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany., Aronson PS; Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA., Köttgen A; Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center and.; CIBSS - Centre for Integrative Biological Signalling Studies, Albert-Ludwigs-University Freiburg, Freiburg, Germany., Jentsch TJ; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Max-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany.; NeuroCure Cluster of Excellence, Charité-Universitätsmedizin Berlin, Berlin, Germany., Knauf F; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2023 Feb 01; Vol. 133 (3). Date of Electronic Publication: 2023 Feb 01.

Dominant negative mutation in oxalate transporter SLC26A6 associated with enteric hyperoxaluria and nephrolithiasis.

Autor: Cornière N; Department of Precision Médicine for Metabolic and Renal Diseases, CHU Amiens Picardie, Université de Picardie Jules Verne, Amiens, France.; UMR1283, INSERM; CNRS; University of Lille, Lille, Hauts de France, France., Thomson RB; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA., Thauvin S; Plateau de Recherche ODHIR, AURAR, Saint-Gilles-les-Bains, Réunion., Villoutreix BO; UMR 1141, INSERM, Paris, Île-de-France, France., Karp S; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA., Dynia DW; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA., Burlein S; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA., Brinkmann L; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA., Badreddine A; UMR1283, INSERM; CNRS; University of Lille, Lille, Hauts de France, France., Dechaume A; UMR1283, INSERM; CNRS; University of Lille, Lille, Hauts de France, France., Derhourhi M; UMR1283, INSERM; CNRS; University of Lille, Lille, Hauts de France, France., Durand E; UMR1283, INSERM; CNRS; University of Lille, Lille, Hauts de France, France., Vaillant E; UMR1283, INSERM; CNRS; University of Lille, Lille, Hauts de France, France., Froguel P; UMR1283, INSERM; CNRS; University of Lille, Lille, Hauts de France, France., Chambrey R; UMR1283, INSERM; CNRS; University of Lille, Lille, Hauts de France, France.; Plateau de Recherche ODHIR, AURAR, Saint-Gilles-les-Bains, Réunion., Aronson PS; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA., Bonnefond A; UMR1283, INSERM; CNRS; University of Lille, Lille, Hauts de France, France., Eladari D; Department of Precision Médicine for Metabolic and Renal Diseases, CHU Amiens Picardie, Université de Picardie Jules Verne, Amiens, France dominique.eladari@inserm.fr.; UMR1283, INSERM; CNRS; University of Lille, Lille, Hauts de France, France.

Publikováno v: Journal of medical genetics [J Med Genet] 2022 Nov; Vol. 59 (11), pp. 1035-1043. Date of Electronic Publication: 2022 Feb 03.

Deletion of Cdh16 Ksp-cadherin leads to a developmental delay in the ability to maximally concentrate urine in mouse.

Autor: Thomson RB; Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut., Dynia DW; Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut., Burlein S; Department of Nephrology and Hypertension, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany., Thomson BR; Feinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Booth CJ; Department of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut., Knauf F; Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany., Wang T; Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut., Aronson PS; Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut.; Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut.

Publikováno v: American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2021 Jun 01; Vol. 320 (6), pp. F1106-F1122. Date of Electronic Publication: 2021 May 03.

Author Reply to Comment on "Assessment of Plasma Oxalate Concentration in Patients With CKD" by Oka et al.

Autor: Pfau A; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany., Wytopil M; Department of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Chauhan K; Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Reichel M; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany., Coca S; Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Aronson PS; Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA., Eckardt KU; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Knauf F; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA.

Publikováno v: Kidney international reports [Kidney Int Rep] 2021 Mar 05; Vol. 6 (4), pp. 1194-1195. Date of Electronic Publication: 2021 Mar 05 (Print Publication: 2021).